- Home
- CRVO vs CLPT Comparison
CRVO vs CLPT Comparison
Compare CRVO & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- CLPT
- Stock Information
- Founded
- CRVO 2001
- CLPT 1998
- Country
- CRVO United States
- CLPT United States
- Employees
- CRVO N/A
- CLPT N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- CRVO Health Care
- CLPT Health Care
- Exchange
- CRVO Nasdaq
- CLPT Nasdaq
- Market Cap
- CRVO 160.4M
- CLPT 146.2M
- IPO Year
- CRVO N/A
- CLPT N/A
- Fundamental
- Price
- CRVO $14.35
- CLPT $11.89
- Analyst Decision
- CRVO Strong Buy
- CLPT Strong Buy
- Analyst Count
- CRVO 4
- CLPT 2
- Target Price
- CRVO $58.25
- CLPT $12.00
- AVG Volume (30 Days)
- CRVO 68.7K
- CLPT 222.1K
- Earning Date
- CRVO 08-09-2024
- CLPT 08-07-2024
- Dividend Yield
- CRVO N/A
- CLPT N/A
- EPS Growth
- CRVO N/A
- CLPT N/A
- EPS
- CRVO N/A
- CLPT N/A
- Revenue
- CRVO $9,653,281.00
- CLPT $28,069,000.00
- Revenue This Year
- CRVO $47.04
- CLPT $33.39
- Revenue Next Year
- CRVO N/A
- CLPT $24.44
- P/E Ratio
- CRVO N/A
- CLPT N/A
- Revenue Growth
- CRVO 585.67
- CLPT 29.33
- 52 Week Low
- CRVO $4.28
- CLPT $4.05
- 52 Week High
- CRVO $26.38
- CLPT $13.47
- Technical
- Relative Strength Index (RSI)
- CRVO 44.99
- CLPT 61.29
- Support Level
- CRVO $16.01
- CLPT $11.95
- Resistance Level
- CRVO $18.63
- CLPT $13.47
- Average True Range (ATR)
- CRVO 1.88
- CLPT 0.84
- MACD
- CRVO -0.15
- CLPT -0.11
- Stochastic Oscillator
- CRVO 7.00
- CLPT 45.52
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.